Your browser doesn't support javascript.
loading
A novel IkB kinase inhibitor attenuates ligature-induced periodontal disease in mice.
Kure, Keitetsu; Sato, Hiroki; Suzuki, Jun-Ichi; Itai, Akiko; Aoyama, Norio; Izumi, Yuichi.
Afiliación
  • Kure K; Department of Periodontology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Sato H; Department of Periodontology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Suzuki JI; Department of Advanced Clinical Science and Therapeutics, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
  • Itai A; Institute of Medical Molecular Design, Inc., Bunkyo-ku, Tokyo, Japan.
  • Aoyama N; Kanagawa Dental University, Yokosuka, Kanagawa, Japan.
  • Izumi Y; Department of Periodontology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
J Periodontal Res ; 54(2): 164-173, 2019 Apr.
Article en En | MEDLINE | ID: mdl-30295325
ABSTRACT
BACKGROUNDS AND

OBJECTIVES:

IMD-0354 is a novel I kappa-B kinase (IKK) inhibitor, which regulates inflammation. The purpose of this study was to examine the effect of the reagent on bone loss for ligature-induced periodontitis. MATERIAL AND

METHODS:

We ligated around the upper right second molars of 8-week-old C57BL/6J mice in the split-mouth model. The test mice were injected intraperitoneally with IMD-0354 before the placement of the ligature. The control mice were injected intraperitoneally with 0.5% carboxymethylcellulose (CMC) as vehicle before the placement of the ligature. To determine the optimum concentration of the reagent on ligature-induced periodontitis in the mice, we examined the effect of three types of concentration, which were 1, 5, and 10 mg/kg of IMD-0354, as a preliminary experiment. After we determined 10 mg/kg as the optimum concentration for the IMD group by micro-CT analysis, both the IMD and CMC groups (n = 15 each in total, including all the analyses) were subdivided into two small groups, respectively, for further analyses I group (unligated side of IMD group), IL group (ligated side of IMD group), C group (unligated side of CMC group) and CL group (ligated side of CMC group). The mice in the IMD and CMC groups were treated with each reagent daily and sacrificed 8 days after the ligation. For assessment of bone resorption, we performed micro-CT and histological analyses. We also carried out real-time PCR to investigate proinflammatory and bone metabolic markers.

RESULTS:

There were significant differences for linear bone loss and volumetric parameter in the test (IMD) group compared to the control (CMC) group 8 days after ligation. In terms of the mRNA expression level of gingival tissue, the level of RANKL was significantly suppressed in the IMD group compared to the CMC group. IMD-0354 also tended to suppress the levels of interleukin-1 beta, tumor necrosis factor-alpha, and osteoprotegerin. For histological analysis, the relative numbers of TRAP-positive multinucleated cells decreased significantly in the IMD group compared to the CMC group.

CONCLUSION:

IMD-0354 regulated bone resorption by ligature-induced periodontitis, and it is suggested that the inhibition of IKK via down-regulation of NF kappa-B may provide periodontal patients with an effective approach to prevent or suppress the disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Periodontitis / Benzamidas / Inhibidores Enzimáticos / Quinasa I-kappa B / Ligadura Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: J Periodontal Res Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Periodontitis / Benzamidas / Inhibidores Enzimáticos / Quinasa I-kappa B / Ligadura Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: J Periodontal Res Año: 2019 Tipo del documento: Article País de afiliación: Japón